Pasturlized cow milk

Phase 1Biologic

HHaEmek Medical Center, Israel

Pasturlized cow milk is one of 16 biologic programs targeting Ulcer Disease. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ulcer DiseaseActive, not recruiting

Ulcer DiseasePhase 1

Active, not recruiting

Competition

Competitive Landscape

16 competitors in Ulcer Disease

#DrugCompanyPhaseTrials

Prevacid

Tracleer

Opsumit

Adempas

Tygacil

PPrism Pharmaceuticals

Approved

—6

Protonix

WWyeth-Lederle Vaccines

Pepcid

Nydrazid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Approved

—9

Cubicin

BBaxter Healthcare Corporation

Approved

—10

Prilosec

DDexcel Pharma Technologies Ltd.

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ulcer Disease1 trial

The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases

Completed·HHaEmek Medical Center, Israel·Phase 1·NCT00333749·65 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Pasturlized cow milk. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pasturlized cow milk compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pasturlized cow milk. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — HaEmek Medical Center, Israel company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 1[1]
Company: HHaEmek Medical Center, Israel

Pasturlized cow milk

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Ulcer Disease1 trial

References

Drug Info

Quick Facts

Related News